LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest and convalescent sera from immunized animals. LLNL researchers have applied their newly developed generalizable screening method to the identification of pathogenic bacteria by screening linear B-cell epitopes in the proteome of Francisella…
Keywords
- Show all (121)
- Instrumentation (38)
- Additive Manufacturing (37)
- Diagnostics (13)
- 3D Printing (7)
- Therapeutics (5)
- Brain Computer Interface (BCI) (3)
- Manufacturing Improvements (3)
- Manufacturing Automation (2)
- Synthesis and Processing (2)
- Electric Grid (1)
- Manufacturing Simulation (1)
- Material Design (1)
- Microfabrication (1)
- Polymer Electrodes (1)
- Precision Engineering (1)
- Rare Earth Elements (REEs) (1)
- Sensors (1)
- Volumetric Additive Manufacturing (1)
- (-) Vaccines (2)
Technology Portfolios
Image
High throughput discovery of linear B-cell epitopes for the development of vaccines and therapeutics
Image
LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a single step. In addition, LLNL has developed a colorimetric assay that indicates production, correct folding, and incorporation of bR into soluble nanolipoprotein particles (NLPs).
LLNL has developed an approach, for formation of NLP/…